Literature DB >> 11703020

In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.

C Brideau1, C Van Staden, C C Chan.   

Abstract

OBJECTIVE: To determine potency and selectivity of nonsteroidal anti-inflammatory drugs (NSAID) and cyclooxygenase- (COX-) specific inhibitors in whole blood from horses, dogs, and cats. SAMPLE POPULATION: Blood samples from 30 healthy horses, 48 healthy dogs, and 9 healthy cats. PROCEDURE: Activities of COX-1 and COX-2 were determined by measuring coagulation-induced thromboxane and lipopolysaccharide-induced prostaglandin E2 concentrations, respectively, in whole blood with and without the addition of various concentrations of phenylbutazone, flunixin meglumine, ketoprofen, diclofenac, indomethacin, meloxicam, carprofen, 5-bromo-2[4-fluorophenyl]-3-14-methylsulfonylphenyl]-thiophene (DuP 697), 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl) phenyl-2(5H)-furan one (DFU), 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone (MF-tricyclic), and celecoxib. Potency of each test compound was determined by calculating the concentration that resulted in inhibition of 50% of COX activity (IC50). Selectivity was determined by calculating the ratio of IC50 for COX-1 to IC50 for COX-2 (COX-1/COX-2 ratio).
RESULTS: The novel compound DFU was the most selective COX-2 inhibitor in equine, canine, and feline blood; COX-1/COX-2 ratios were 775, 74, and 69, respectively. Carprofen was the weakest inhibitor of COX-2, compared with the other COX-2 selective inhibitors, and did not inhibit COX-2 activity in equine blood. In contrast, NSAID such as phenylbutazone and flunixin meglumine were more potent inhibitors of COX-1 than COX-2 in canine and equine blood. CONCLUSIONS AND CLINICAL RELEVANCE: The novel COX-2 inhibitor DFU was more potent and selective in canine, equine, and feline blood, compared with phenylbutazone, flunixin meglumine, and carprofen. Compounds that specifically inhibit COX-2 may result in a lower incidence of adverse effects, compared with NSAID, when administered at therapeutic dosages to horses, dogs, and cats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703020     DOI: 10.2460/ajvr.2001.62.1755

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  29 in total

1.  Pharmacology of drugs used to treat osteoarthritis in veterinary practice.

Authors:  Peter Lees
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

2.  NSAIDs and scavenging birds: potential impacts beyond Asia's critically endangered vultures.

Authors:  Richard Cuthbert; Jemima Parry-Jones; Rhys E Green; Deborah J Pain
Journal:  Biol Lett       Date:  2007-02-22       Impact factor: 3.703

3.  Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat.

Authors:  Alexandra Wibberley; Gerald P McCafferty; Christopher Evans; Richard M Edwards; J Paul Hieble
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

4.  Administration of the nonsteroidal anti-inflammatory drug tolfenamic acid at embryo transfer improves maintenance of pregnancy and embryo survival in recipient mice.

Authors:  Geraldine Schlapp; Lucía Goyeneche; Gabriel Fernández; Alejo Menchaca; Martina Crispo
Journal:  J Assist Reprod Genet       Date:  2015-01-06       Impact factor: 3.412

Review 5.  Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.

Authors:  Amanda Ziegler; Callie Fogle; Anthony Blikslager
Journal:  J Am Vet Med Assoc       Date:  2017-06-01       Impact factor: 1.936

6.  Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administered orally in Holstein-Friesian cows.

Authors:  P R Malreddy; J F Coetzee; B Kukanich; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2012-02-28       Impact factor: 1.786

7.  Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).

Authors:  Cassondra Bauer; Patrice Frost; Stephen Kirschner
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

8.  Hypoactivity of rat detrusor muscle in a model of cystitis: exacerbation by non-selective COX inhibitors and amelioration by a selective DP1 receptor antagonist.

Authors:  Wesam Bassiouni; Tahia Daabees; Xavier Norel; Amira M Senbel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-14       Impact factor: 3.000

9.  Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL/6 mice.

Authors:  Joelle C Ingrao; Ron Johnson; Elizabeth Tor; Yu Gu; Marcus Litman; Patricia V Turner
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

10.  Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution.

Authors:  L C Freeman; D F Narvaez; A McCoy; F B von Stein; S Young; K Silver; S Ganta; D Koch; R Hunter; R F Gilmour; J D Lillich
Journal:  Biochem Pharmacol       Date:  2007-04-04       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.